The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in ...

Antag Therapeutics has initiated a first-in-human, double-blind Phase Ia trial of the glucose-dependent insulinotropic ...

The following is a summary of “Trending Modalities in Type 2 Diabetes Prevention,” published in the February 2025 issue of Journal of Clinical Endocrinology & Metabolism by Lundgrin & Hatipoglu. A ...

Both Jeremy Clarkson and Amy Schumer have switched to a new weight loss drug having struggled to cope with the side effects ...

A Medicine study used artificial intelligence to discover a naturally occurring molecule, specifically, a peptide, that ...

Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported ...

GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.

Jeremy Clarkson and Amy Schumer have both shared the struggles they had with the injections, which are designed as a ...

Lexicon eligible to receive up to $1 billion in upfront and development, regulatory and sales milestone payments, including $75 million in upfront and ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...